Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Paul Bunn

Concepts (1215)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
343
2024
2323
20.450
Why?
Carcinoma, Non-Small-Cell Lung
171
2024
1044
15.830
Why?
ErbB Receptors
69
2024
601
6.630
Why?
Antineoplastic Agents
103
2023
2058
6.010
Why?
Antineoplastic Combined Chemotherapy Protocols
95
2024
1565
5.720
Why?
Carcinoma, Small Cell
105
2008
168
5.090
Why?
Small Cell Lung Carcinoma
14
2024
88
4.640
Why?
Quinazolines
38
2016
242
4.570
Why?
Protein Kinase Inhibitors
32
2023
872
3.250
Why?
Paclitaxel
31
2011
214
2.630
Why?
Carboplatin
24
2019
139
2.320
Why?
Guanine
11
2007
76
2.130
Why?
Deoxycytidine
14
2004
164
2.030
Why?
Glutamates
11
2007
56
1.940
Why?
Molecular Targeted Therapy
13
2019
387
1.900
Why?
Neoplasm Staging
63
2018
1288
1.840
Why?
Adenocarcinoma
31
2017
888
1.770
Why?
Antibodies, Monoclonal
45
2018
1355
1.720
Why?
Biomarkers, Tumor
37
2021
1182
1.630
Why?
Humans
525
2024
128524
1.630
Why?
Neoadjuvant Therapy
9
2023
380
1.460
Why?
Antimetabolites, Antineoplastic
10
2007
90
1.450
Why?
Taxoids
13
2013
95
1.440
Why?
Receptor, ErbB-2
12
2019
336
1.430
Why?
Mutation
30
2024
3692
1.400
Why?
Skin Neoplasms
55
2010
832
1.360
Why?
Clinical Trials as Topic
51
2024
998
1.350
Why?
Gene Expression Regulation, Neoplastic
24
2018
1333
1.320
Why?
Lymphoma
47
1991
194
1.270
Why?
Combined Modality Therapy
52
2023
1209
1.260
Why?
Antineoplastic Agents, Phytogenic
10
2007
186
1.240
Why?
Etoposide
26
2023
149
1.220
Why?
Survival Analysis
34
2019
1265
1.130
Why?
Cisplatin
31
2018
297
1.130
Why?
Vinblastine
8
2003
68
1.120
Why?
Carcinoma, Squamous Cell
21
2023
620
1.120
Why?
Sezary Syndrome
36
1996
43
1.090
Why?
Protein-Tyrosine Kinases
10
2023
430
1.080
Why?
Lymphoma, T-Cell, Cutaneous
9
2010
42
1.040
Why?
Drug Resistance, Neoplasm
19
2023
749
1.020
Why?
Mycosis Fungoides
38
1996
62
1.010
Why?
Antibodies, Monoclonal, Humanized
14
2023
759
1.000
Why?
Aged
142
2024
21971
0.990
Why?
Erlotinib Hydrochloride
12
2015
68
0.990
Why?
In Situ Hybridization, Fluorescence
22
2018
313
0.980
Why?
Precision Medicine
5
2024
383
0.950
Why?
Bradykinin
9
2005
45
0.950
Why?
Liposomes
3
2024
168
0.940
Why?
Pemetrexed
14
2024
32
0.940
Why?
Tumor Cells, Cultured
31
2014
927
0.900
Why?
Immunotherapy
13
2020
585
0.880
Why?
Middle Aged
169
2024
30893
0.880
Why?
Proto-Oncogene Proteins
15
2023
634
0.870
Why?
Folic Acid Antagonists
4
2005
9
0.860
Why?
Angiogenesis Inhibitors
8
2018
216
0.840
Why?
Prognosis
52
2019
3780
0.820
Why?
Gene Dosage
10
2018
142
0.800
Why?
Male
205
2024
62883
0.780
Why?
Immunohistochemistry
25
2020
1669
0.770
Why?
Neutropenia
12
2022
136
0.770
Why?
Female
198
2024
68127
0.760
Why?
Survival Rate
23
2020
1872
0.740
Why?
Antigens, Neoplasm
14
2009
310
0.730
Why?
Enzyme Inhibitors
10
2016
811
0.720
Why?
Gene Amplification
9
2019
103
0.720
Why?
Receptor Protein-Tyrosine Kinases
10
2022
221
0.710
Why?
Smoking
20
2019
1463
0.700
Why?
Chemotherapy, Adjuvant
10
2015
376
0.680
Why?
Retirement
1
2020
26
0.660
Why?
Medical Oncology
6
2003
272
0.650
Why?
Brain Neoplasms
18
2023
1149
0.640
Why?
Pathologists
1
2019
17
0.630
Why?
Treatment Outcome
42
2023
10163
0.620
Why?
Tubulin Modulators
1
2018
9
0.590
Why?
Aged, 80 and over
36
2024
7040
0.590
Why?
Furans
1
2018
22
0.590
Why?
Sputum
11
2019
304
0.580
Why?
Ketones
1
2018
47
0.570
Why?
Acrylamides
3
2024
58
0.570
Why?
T-Lymphocytes
54
2020
1922
0.560
Why?
Randomized Controlled Trials as Topic
20
2018
1358
0.560
Why?
Karnofsky Performance Status
1
2016
38
0.540
Why?
Global Health
3
2024
326
0.540
Why?
Aurora Kinase B
1
2016
8
0.540
Why?
Thymidylate Synthase
4
2005
12
0.530
Why?
Cell Division
23
2007
779
0.530
Why?
Sulindac
5
2007
15
0.520
Why?
Proto-Oncogene Proteins c-met
6
2020
74
0.520
Why?
Interferon Type I
12
1995
140
0.510
Why?
Pneumonectomy
3
2015
150
0.510
Why?
Dose-Response Relationship, Drug
22
2016
1943
0.500
Why?
Awards and Prizes
1
2016
62
0.500
Why?
Neoplasm Proteins
5
2009
421
0.500
Why?
Organophosphates
1
2016
120
0.490
Why?
Gene Rearrangement
8
2018
145
0.490
Why?
Adult
123
2024
35315
0.480
Why?
Cell Cycle
12
2015
581
0.480
Why?
Precancerous Conditions
7
2018
161
0.470
Why?
Cell Line, Tumor
18
2019
3160
0.460
Why?
Chemoprevention
5
2019
89
0.450
Why?
Genomics
3
2020
716
0.440
Why?
Genes, erbB-2
8
2017
28
0.430
Why?
Esophagitis
3
2012
66
0.430
Why?
Disease Progression
15
2024
2603
0.430
Why?
Neoplasms
10
2010
2465
0.420
Why?
Genes, erbB-1
6
2015
17
0.420
Why?
Cadherins
6
2012
186
0.420
Why?
Cell Transformation, Neoplastic
6
2004
325
0.410
Why?
Aniline Compounds
2
2024
98
0.410
Why?
AMP-Activated Protein Kinases
1
2014
190
0.400
Why?
Neoplasm Metastasis
16
2024
608
0.390
Why?
Mass Screening
6
2020
1152
0.390
Why?
Ribonucleotide Reductases
4
2004
22
0.390
Why?
Neoplasm Recurrence, Local
10
2024
957
0.380
Why?
Mice, Nude
18
2017
682
0.380
Why?
Disease-Free Survival
11
2018
656
0.380
Why?
Drug Screening Assays, Antitumor
10
2009
194
0.380
Why?
Neuropeptides
6
1998
72
0.370
Why?
Drug Administration Schedule
18
2011
757
0.370
Why?
Melanoma
5
2022
749
0.370
Why?
Pyridines
6
2013
469
0.370
Why?
TOR Serine-Threonine Kinases
1
2014
380
0.360
Why?
Early Detection of Cancer
7
2024
368
0.360
Why?
Proto-Oncogene Proteins p21(ras)
9
2019
259
0.360
Why?
Bronchi
7
2018
240
0.360
Why?
National Cancer Institute (U.S.)
1
2010
43
0.350
Why?
Esophagus
1
2012
248
0.350
Why?
Time Factors
33
2018
6503
0.340
Why?
Signal Transduction
18
2017
4829
0.340
Why?
Animals
67
2019
34501
0.330
Why?
Head and Neck Neoplasms
4
2009
534
0.330
Why?
Genotype
2
2014
1831
0.330
Why?
Fever
5
2001
301
0.330
Why?
Cell Proliferation
9
2018
2335
0.320
Why?
Drug Delivery Systems
2
2010
326
0.320
Why?
Predictive Value of Tests
12
2014
1936
0.320
Why?
Drug Monitoring
1
2010
184
0.320
Why?
Phosphorylation
6
2016
1681
0.310
Why?
Biomedical Research
5
2024
646
0.310
Why?
Receptors, Vascular Endothelial Growth Factor
3
2009
89
0.310
Why?
B7-H1 Antigen
2
2022
185
0.310
Why?
Salvage Therapy
2
2007
137
0.300
Why?
Calcium
6
2002
1178
0.300
Why?
Drug Therapy, Combination
28
2002
1009
0.300
Why?
Topotecan
3
2024
12
0.300
Why?
Pyrazoles
5
2013
400
0.300
Why?
Xenograft Model Antitumor Assays
8
2019
810
0.290
Why?
Lymphoma, Non-Hodgkin
6
2001
76
0.290
Why?
Meta-Analysis as Topic
6
2017
167
0.280
Why?
Flow Cytometry
14
2006
1141
0.280
Why?
Cancer Vaccines
1
2009
165
0.280
Why?
Mesothelioma
3
2004
38
0.280
Why?
Neoplasms, Experimental
4
2002
169
0.280
Why?
Biomarkers
4
2023
3881
0.280
Why?
Radiation-Sensitizing Agents
2
1997
40
0.270
Why?
Leukemia
16
2018
229
0.270
Why?
Receptors, KIR
2
2018
96
0.270
Why?
Camptothecin
5
2017
107
0.270
Why?
Oligopeptides
4
2005
257
0.260
Why?
ras Proteins
7
2014
145
0.260
Why?
Protease Inhibitors
2
2004
103
0.260
Why?
Gene Expression Profiling
9
2016
1687
0.260
Why?
Oncogene Proteins, Fusion
3
2018
198
0.260
Why?
Phosphatidylinositol 3-Kinases
4
2023
357
0.250
Why?
Lung
14
2023
3741
0.250
Why?
Bradykinin Receptor Antagonists
2
2002
2
0.250
Why?
Interferons
7
1995
192
0.250
Why?
Mice
32
2019
16579
0.250
Why?
Thrombocytopenia
8
2001
182
0.250
Why?
Carcinoma in Situ
4
2019
45
0.250
Why?
Proto-Oncogene Proteins B-raf
5
2015
214
0.250
Why?
Recombinant Proteins
14
1998
1284
0.250
Why?
Apoptosis
9
2018
2437
0.240
Why?
Topoisomerase I Inhibitors
3
2024
17
0.240
Why?
Antigens, Surface
10
1988
150
0.240
Why?
Cyclooxygenase Inhibitors
2
2002
80
0.240
Why?
Genes, ras
5
2015
98
0.240
Why?
Tankyrases
2
2016
13
0.230
Why?
Indium Radioisotopes
5
1991
13
0.230
Why?
Breast Neoplasms
9
2018
2139
0.230
Why?
Asymptomatic Infections
1
2024
23
0.230
Why?
Radiotherapy Dosage
13
2007
248
0.230
Why?
Neovascularization, Pathologic
7
2015
291
0.230
Why?
Boronic Acids
1
2004
37
0.230
Why?
Committee Membership
1
2003
2
0.220
Why?
Leukemia, Lymphoid
7
1987
27
0.220
Why?
Transplantation, Heterologous
9
2006
187
0.220
Why?
Volatile Organic Compounds
3
2013
54
0.220
Why?
Organophosphorus Compounds
1
2004
77
0.220
Why?
Organizational Objectives
1
2003
70
0.220
Why?
United States
22
2020
13876
0.210
Why?
Liver Neoplasms
7
2015
640
0.210
Why?
Retrospective Studies
19
2024
14460
0.210
Why?
Pyrazines
1
2004
88
0.210
Why?
Anticarcinogenic Agents
1
2004
77
0.210
Why?
Oncogene Addiction
1
2023
5
0.210
Why?
Delivery of Health Care
1
2010
892
0.210
Why?
HTLV-I Infections
2
1996
22
0.210
Why?
Tumor Microenvironment
3
2023
618
0.210
Why?
Follow-Up Studies
18
2019
4898
0.210
Why?
Neoplasm Transplantation
11
2004
258
0.210
Why?
Receptor, ErbB-3
3
2009
45
0.200
Why?
Bronchoscopy
10
2019
208
0.200
Why?
Doxorubicin
22
2002
322
0.200
Why?
Cluster Analysis
4
2016
478
0.200
Why?
Penicillins
22
1969
54
0.200
Why?
Airway Obstruction
2
2003
149
0.200
Why?
Anti-Bacterial Agents
23
2001
1667
0.200
Why?
Drug Synergism
6
2016
358
0.200
Why?
Organoplatinum Compounds
3
2006
40
0.200
Why?
Iodine Radioisotopes
5
1992
142
0.200
Why?
Growth Substances
4
2000
151
0.200
Why?
Biopsy
12
2023
1085
0.190
Why?
Carcinoma, Bronchogenic
10
1984
19
0.190
Why?
Alkyl and Aryl Transferases
1
2002
53
0.190
Why?
Roxithromycin
1
2001
1
0.190
Why?
Carcinoma, Transitional Cell
1
2022
60
0.190
Why?
Iloprost
2
2012
45
0.190
Why?
Societies
1
2001
36
0.190
Why?
DNA, Neoplasm
8
2013
159
0.190
Why?
Research Design
7
2008
1038
0.190
Why?
Biological Products
2
2023
200
0.180
Why?
Neprilysin
2
1998
47
0.180
Why?
Quality of Life
5
2022
2680
0.180
Why?
Biomarkers, Pharmacological
2
2019
26
0.180
Why?
Diarrhea
1
2022
177
0.180
Why?
Cell Line
24
2000
2731
0.180
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
2
2014
136
0.180
Why?
Pleural Neoplasms
2
2016
23
0.180
Why?
Cell Cycle Checkpoints
2
2018
95
0.180
Why?
Antibiotic Prophylaxis
1
2001
94
0.180
Why?
Prospective Studies
15
2023
7043
0.180
Why?
Artificial Intelligence
1
2023
246
0.170
Why?
Smoking Prevention
1
2001
162
0.170
Why?
Societies, Medical
2
2003
749
0.170
Why?
Programmed Cell Death 1 Receptor
2
2022
226
0.170
Why?
DNA Copy Number Variations
2
2018
169
0.170
Why?
Ki-67 Antigen
4
2015
106
0.170
Why?
Age Factors
7
2016
3117
0.170
Why?
Adenocarcinoma, Bronchiolo-Alveolar
4
2012
19
0.170
Why?
Oncogenes
4
2016
109
0.170
Why?
Patient Participation
1
2003
407
0.170
Why?
GTP Phosphohydrolases
3
2015
77
0.160
Why?
Carcinoma, Large Cell
4
2012
15
0.160
Why?
Vaping
1
2020
55
0.160
Why?
Urinary Bladder Neoplasms
1
2022
226
0.160
Why?
Epidermal Growth Factor
4
2013
169
0.160
Why?
Histone Deacetylase Inhibitors
3
2012
206
0.160
Why?
Lymph Nodes
17
1991
467
0.160
Why?
Kaplan-Meier Estimate
6
2016
857
0.160
Why?
Antibodies, Viral
12
2024
593
0.160
Why?
Aminoquinolines
1
2019
21
0.160
Why?
Neuroendocrine Tumors
1
2020
99
0.160
Why?
Electronic Nicotine Delivery Systems
1
2020
89
0.150
Why?
Practice Guidelines as Topic
3
2019
1490
0.150
Why?
Friends
1
2019
51
0.150
Why?
Structure-Activity Relationship
6
2018
530
0.150
Why?
Trastuzumab
4
2002
100
0.150
Why?
Gene Expression
6
2008
1462
0.150
Why?
Radiotherapy, Adjuvant
3
2004
211
0.150
Why?
DNA Methylation
3
2018
604
0.150
Why?
Genetic Predisposition to Disease
3
2011
2266
0.150
Why?
Wasting Syndrome
1
1998
11
0.150
Why?
Homeodomain Proteins
3
2010
487
0.150
Why?
Leukemia-Lymphoma, Adult T-Cell
2
1996
13
0.150
Why?
History, 21st Century
1
2019
180
0.150
Why?
Clinical Trials, Phase II as Topic
3
2004
71
0.150
Why?
Caspase 3
2
2018
229
0.150
Why?
Receptor, IGF Type 1
2
2010
65
0.150
Why?
Interferon-alpha
4
1995
192
0.150
Why?
Immunoenzyme Techniques
5
2014
206
0.150
Why?
Tumor Escape
1
2018
38
0.150
Why?
Proto-Oncogenes
2
2014
29
0.150
Why?
Forecasting
4
2003
358
0.140
Why?
Lung Injury
1
2020
199
0.140
Why?
Young Adult
10
2020
12320
0.140
Why?
Smoking Cessation
3
2019
408
0.140
Why?
Cranial Irradiation
2
1995
68
0.140
Why?
CpG Islands
1
2018
152
0.140
Why?
Lung Diseases
6
2015
722
0.140
Why?
Folic Acid
4
2002
183
0.140
Why?
Genetic Association Studies
2
2017
359
0.140
Why?
Vitamin B 12
3
2002
122
0.140
Why?
Mutagenesis, Insertional
1
2017
65
0.140
Why?
Clinical Protocols
1
2019
253
0.140
Why?
Bone Marrow
10
1992
267
0.140
Why?
Multiple Myeloma
5
1997
123
0.140
Why?
Cyclophosphamide
19
2001
231
0.140
Why?
Cetuximab
4
2008
94
0.140
Why?
Drug Evaluation
15
1992
80
0.140
Why?
Receptors, KIR2DL3
1
2016
9
0.140
Why?
Receptors, KIR2DL4
1
2016
4
0.140
Why?
Proportional Hazards Models
6
2016
1208
0.140
Why?
Palliative Care
6
2003
716
0.140
Why?
HLA Antigens
4
1988
235
0.140
Why?
Receptors, KIR2DL1
1
2016
18
0.140
Why?
Receptors, KIR3DL1
1
2016
17
0.140
Why?
Tumor Suppressor Protein p53
2
2017
507
0.140
Why?
Patients
1
2018
166
0.130
Why?
Interleukin-2
3
1995
430
0.130
Why?
Polyploidy
1
2016
18
0.130
Why?
DNA Mutational Analysis
6
2017
386
0.130
Why?
Genes, myc
1
2016
50
0.130
Why?
RNA, Messenger
7
2014
2674
0.130
Why?
Chemoradiotherapy
1
2018
209
0.130
Why?
Patient Selection
7
2008
661
0.130
Why?
Pleural Effusion, Malignant
1
2016
10
0.130
Why?
Granulocyte Colony-Stimulating Factor
4
2001
71
0.130
Why?
Translocation, Genetic
1
2016
97
0.130
Why?
Bone Neoplasms
4
2015
229
0.130
Why?
Lymphoma, AIDS-Related
1
1996
14
0.130
Why?
Genetic Therapy
4
2015
293
0.130
Why?
Clinical Trials, Phase III as Topic
3
2016
90
0.130
Why?
Empathy
2
2009
171
0.130
Why?
Human T-lymphotropic virus 1
1
1996
28
0.130
Why?
Dimerization
3
2002
188
0.130
Why?
Computational Biology
2
2018
597
0.130
Why?
Molecular Biology
1
2016
55
0.120
Why?
Cohort Studies
9
2019
5369
0.120
Why?
Radiosurgery
2
2014
317
0.120
Why?
Disease Models, Animal
5
2016
3943
0.120
Why?
Peritoneal Neoplasms
1
2016
86
0.120
Why?
Nerve Tissue Proteins
1
1999
567
0.120
Why?
Membrane Proteins
3
2015
1108
0.120
Why?
Tumor Burden
1
2016
282
0.120
Why?
Ifosfamide
4
2008
34
0.120
Why?
Remission Induction
7
2019
269
0.120
Why?
Sex Factors
6
2015
1949
0.120
Why?
Patient-Specific Modeling
1
2014
38
0.120
Why?
Lymphocytes, Tumor-Infiltrating
1
2016
209
0.120
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1995
147
0.120
Why?
Up-Regulation
3
2002
826
0.120
Why?
Amino Acid Sequence
6
1999
2041
0.120
Why?
HIV
1
1996
226
0.110
Why?
Prevalence
4
2023
2549
0.110
Why?
Administration, Oral
5
2012
757
0.110
Why?
Biosensing Techniques
2
2013
114
0.110
Why?
Bronchopulmonary Dysplasia
1
2019
375
0.110
Why?
Adrenal Gland Neoplasms
1
2015
83
0.110
Why?
Correction of Hearing Impairment
1
2014
15
0.110
Why?
Tomography, Spiral Computed
1
2013
27
0.110
Why?
Transcription Factors
3
2010
1631
0.110
Why?
Attitude to Computers
1
2014
28
0.110
Why?
Lymph Node Excision
1
2015
165
0.110
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2014
52
0.110
Why?
Persons With Hearing Impairments
1
2014
22
0.110
Why?
Genetic Testing
2
2011
427
0.110
Why?
PUVA Therapy
3
1990
6
0.110
Why?
Interferon-gamma
3
1995
761
0.110
Why?
Multiplex Polymerase Chain Reaction
1
2014
51
0.110
Why?
Activities of Daily Living
1
2016
388
0.110
Why?
Inhibitory Concentration 50
3
2013
81
0.100
Why?
Proto-Oncogene Proteins c-akt
5
2015
421
0.100
Why?
Deltaretrovirus Infections
3
1988
6
0.100
Why?
Retroviridae
9
1983
97
0.100
Why?
Sequence Analysis, DNA
2
2014
773
0.100
Why?
Wnt Proteins
2
2012
126
0.100
Why?
Physicians
2
2019
860
0.100
Why?
Hearing Aids
1
2014
74
0.100
Why?
Hypogonadism
1
2013
82
0.100
Why?
DNA
6
1983
1392
0.100
Why?
Hyperplasia
2
2011
170
0.100
Why?
Loss of Heterozygosity
2
2002
46
0.100
Why?
Radioimmunotherapy
1
1992
14
0.100
Why?
Software
1
2017
610
0.100
Why?
Neurosecretory Systems
2
2017
30
0.100
Why?
Polymerase Chain Reaction
3
2006
1019
0.100
Why?
Risk Assessment
5
2010
3256
0.100
Why?
Genetic Variation
1
2017
934
0.090
Why?
Risk Factors
9
2019
9727
0.090
Why?
Androgens
1
2013
174
0.090
Why?
Reverse Transcriptase Polymerase Chain Reaction
6
2014
937
0.090
Why?
Meningeal Neoplasms
4
1986
90
0.090
Why?
Prostatic Neoplasms
5
2018
1010
0.090
Why?
Molecular Sequence Data
6
1999
2818
0.090
Why?
Benzamides
1
2012
194
0.090
Why?
Clinical Trials, Phase I as Topic
2
2002
49
0.090
Why?
Histones
1
2016
581
0.090
Why?
Chromosomes, Human, Pair 15
1
2011
56
0.090
Why?
Deltaretrovirus
6
1986
12
0.090
Why?
Class I Phosphatidylinositol 3-Kinases
3
2015
81
0.090
Why?
Antibiotics, Antitubercular
11
1961
36
0.090
Why?
MAP Kinase Kinase 1
3
2015
76
0.090
Why?
Cervical Vertebrae
2
2002
130
0.090
Why?
Antibody Formation
2
2022
287
0.090
Why?
Gold
1
2011
117
0.090
Why?
Cognition
2
2009
1107
0.090
Why?
Zinc Finger E-box-Binding Homeobox 1
2
2010
22
0.090
Why?
Hearing Loss
1
2014
209
0.090
Why?
Molecular Structure
2
2005
465
0.090
Why?
Isoenzymes
2
2004
304
0.090
Why?
Pulmonary Surgical Procedures
1
2010
8
0.090
Why?
Radionuclide Imaging
13
1991
123
0.090
Why?
Transcriptome
1
2016
881
0.090
Why?
Mucins
1
1990
69
0.080
Why?
Dermatologic Agents
11
1961
65
0.080
Why?
Stomach Neoplasms
3
1982
98
0.080
Why?
Tuberculosis
19
1970
275
0.080
Why?
Indium
5
1987
9
0.080
Why?
Radiography
9
2002
864
0.080
Why?
Placebos
3
2019
201
0.080
Why?
Random Allocation
7
2017
346
0.080
Why?
Neoplasm Invasiveness
3
2015
480
0.080
Why?
Expressed Emotion
1
2009
18
0.080
Why?
Tumor Virus Infections
3
1984
45
0.080
Why?
Tocopherols
1
2009
22
0.080
Why?
Lymphoma, B-Cell
1
2010
104
0.080
Why?
Testosterone
1
2013
378
0.080
Why?
Isotretinoin
1
2009
23
0.080
Why?
Antibodies, Neoplasm
4
2001
35
0.080
Why?
Vasodilator Agents
1
2011
321
0.080
Why?
Central Nervous System Diseases
2
1983
66
0.080
Why?
Pulmonary Disease, Chronic Obstructive
2
2007
950
0.080
Why?
Blotting, Western
6
2014
1168
0.080
Why?
Staphylococcal Infections
7
1981
380
0.080
Why?
Catheter Ablation
1
2012
332
0.080
Why?
Kanamycin
6
1970
8
0.080
Why?
Wounds, Nonpenetrating
2
2002
283
0.080
Why?
Spinal Cord Neoplasms
4
1986
39
0.080
Why?
Fluorenes
1
2009
40
0.080
Why?
Mitogen-Activated Protein Kinases
2
2002
313
0.080
Why?
MicroRNAs
2
2012
671
0.080
Why?
Rats
6
2005
5168
0.080
Why?
Receptors, Fibroblast Growth Factor
1
2008
65
0.080
Why?
Podophyllotoxin
3
2003
7
0.080
Why?
Aneuploidy
5
2010
92
0.080
Why?
Reproducibility of Results
4
2023
3023
0.080
Why?
Cell Survival
5
2013
1077
0.080
Why?
Vincristine
13
1989
110
0.070
Why?
Amides
1
2009
91
0.070
Why?
Rats, Nude
4
2003
27
0.070
Why?
Multigene Family
2
2006
198
0.070
Why?
Lymphatic Metastasis
6
2020
318
0.070
Why?
Mice, Inbred BALB C
4
2004
1229
0.070
Why?
Social Perception
1
2009
104
0.070
Why?
National Institutes of Health (U.S.)
4
1996
123
0.070
Why?
Antisocial Personality Disorder
1
2009
162
0.070
Why?
Sample Size
1
2008
115
0.070
Why?
Polymorphism, Genetic
1
2011
639
0.070
Why?
Kinetics
8
1991
1616
0.070
Why?
Multivariate Analysis
5
2016
1494
0.070
Why?
Chromosome Aberrations
6
1993
147
0.070
Why?
Patient Acceptance of Health Care
1
2014
764
0.070
Why?
Bombesin
3
1994
12
0.070
Why?
Models, Statistical
1
1991
625
0.070
Why?
Inflammation
1
2018
2664
0.070
Why?
Drug Evaluation, Preclinical
2
2002
168
0.070
Why?
Nanoparticles
1
2011
368
0.070
Why?
Fibroblast Growth Factors
1
2008
171
0.070
Why?
Immunoglobulins
2
1985
157
0.070
Why?
Exons
2
2019
337
0.070
Why?
Epithelial Cells
4
2007
1036
0.070
Why?
Receptors, Growth Factor
2
1997
46
0.070
Why?
Incidence
3
2018
2619
0.070
Why?
Epitopes
3
1986
466
0.070
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2002
343
0.070
Why?
Psychological Tests
1
2007
131
0.070
Why?
Congresses as Topic
3
2020
214
0.070
Why?
Radioisotopes
4
1987
31
0.070
Why?
Databases, Genetic
2
2018
228
0.070
Why?
Bevacizumab
1
2007
131
0.070
Why?
Mesoderm
1
2007
136
0.070
Why?
Cytokines
4
1997
1985
0.060
Why?
Radioimmunoassay
3
1986
169
0.060
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
1987
64
0.060
Why?
Tegafur
1
2005
3
0.060
Why?
Immunologic Factors
3
1996
229
0.060
Why?
Platinum Compounds
1
2005
10
0.060
Why?
Uracil
1
2005
29
0.060
Why?
Teniposide
2
2003
3
0.060
Why?
Aging
2
2014
1770
0.060
Why?
Receptors, Cell Surface
2
2001
371
0.060
Why?
Area Under Curve
2
2005
281
0.060
Why?
In Situ Nick-End Labeling
2
2003
120
0.060
Why?
Vascular Endothelial Growth Factor A
1
2008
501
0.060
Why?
beta 2-Microglobulin
1
1985
47
0.060
Why?
Health Knowledge, Attitudes, Practice
1
2014
1271
0.060
Why?
Resting Phase, Cell Cycle
1
2005
15
0.060
Why?
Anti-Infective Agents
4
2001
225
0.060
Why?
Adolescent
10
2020
20213
0.060
Why?
Matrix Metalloproteinase Inhibitors
2
2005
15
0.060
Why?
PTEN Phosphohydrolase
1
2006
157
0.060
Why?
Affect
1
2007
285
0.060
Why?
Drug Resistance
5
2006
163
0.060
Why?
G1 Phase
1
2005
71
0.060
Why?
Radiation, Ionizing
1
2005
75
0.060
Why?
Binding Sites, Antibody
1
1984
42
0.060
Why?
Injections, Subcutaneous
3
2002
145
0.060
Why?
Regression Analysis
3
2003
983
0.060
Why?
Selenium
2
2004
36
0.060
Why?
Drug Therapy
5
1983
76
0.060
Why?
Animal Welfare
1
2004
13
0.060
Why?
Bortezomib
1
2004
44
0.060
Why?
Data Collection
1
2007
649
0.060
Why?
High-Throughput Nucleotide Sequencing
2
2018
485
0.060
Why?
Radiotherapy
6
1994
185
0.060
Why?
Biological Therapy
1
2004
29
0.060
Why?
Retroviridae Infections
4
1985
46
0.060
Why?
JNK Mitogen-Activated Protein Kinases
2
2002
160
0.060
Why?
Karyotyping
6
1996
107
0.060
Why?
Retinoids
1
2004
34
0.060
Why?
Planning Techniques
1
2003
16
0.060
Why?
Prostaglandin-Endoperoxide Synthases
1
2004
73
0.060
Why?
Decision Making, Organizational
1
2003
25
0.060
Why?
Immunologic Tests
1
2023
16
0.060
Why?
Lymphoma, Large B-Cell, Diffuse
3
1976
113
0.060
Why?
Nucleocapsid
1
2023
18
0.050
Why?
Surveys and Questionnaires
4
2014
5346
0.050
Why?
Biotechnology
1
2004
40
0.050
Why?
Vaccination
2
2022
1336
0.050
Why?
Lymphocytes
1
1985
366
0.050
Why?
Vitamin E
1
2004
117
0.050
Why?
Transfection
1
2006
895
0.050
Why?
Necrosis
1
2004
231
0.050
Why?
Nervous System Neoplasms
1
1983
2
0.050
Why?
Methotrexate
11
1986
249
0.050
Why?
Immunotoxins
2
1995
51
0.050
Why?
Diagnostic Imaging
2
2009
330
0.050
Why?
Cyclooxygenase 2
1
2004
172
0.050
Why?
Radiation Tolerance
1
2004
97
0.050
Why?
Pilot Projects
3
2012
1558
0.050
Why?
Methylmalonic Acid
1
2002
62
0.050
Why?
Meninges
4
1982
40
0.050
Why?
Fruit
1
2003
131
0.050
Why?
Pandemics
2
2022
1487
0.050
Why?
Killer Cells, Natural
2
1988
425
0.050
Why?
Proteomics
3
2007
1004
0.050
Why?
Enzyme Activation
2
2002
799
0.050
Why?
Epithelial-Mesenchymal Transition
2
2017
194
0.050
Why?
Farnesyltranstransferase
1
2002
35
0.050
Why?
Vegetables
1
2003
147
0.050
Why?
Metaplasia
2
2018
54
0.050
Why?
Automation
1
2002
80
0.050
Why?
Streptozocin
3
1983
16
0.050
Why?
Skin
7
1987
717
0.050
Why?
Autoradiography
3
1981
74
0.050
Why?
Oligonucleotide Array Sequence Analysis
4
2007
756
0.050
Why?
Injections, Intralesional
1
2002
34
0.050
Why?
Infusion Pumps
1
2002
31
0.050
Why?
Parents
2
2009
1306
0.050
Why?
Tetrazolium Salts
1
2002
17
0.050
Why?
Injections, Intraperitoneal
1
2002
105
0.050
Why?
Homocysteine
1
2002
151
0.050
Why?
SEER Program
1
2003
206
0.050
Why?
Hypercalcemia
4
1986
19
0.050
Why?
Peptides
3
2001
909
0.050
Why?
Proteome
1
2006
431
0.050
Why?
Antigen-Antibody Complex
4
1986
84
0.050
Why?
Mechlorethamine
3
1994
56
0.050
Why?
Metalloendopeptidases
2
2002
58
0.050
Why?
Testis
1
2002
144
0.050
Why?
Mediastinal Neoplasms
1
2002
38
0.050
Why?
Infusions, Intravenous
3
2004
384
0.050
Why?
Indoles
1
2024
367
0.050
Why?
Multicenter Studies as Topic
1
2003
285
0.050
Why?
Ciprofloxacin
1
2001
27
0.050
Why?
Dietary Supplements
2
2004
529
0.050
Why?
Thiazoles
1
2002
115
0.050
Why?
Confidence Intervals
2
2017
318
0.050
Why?
Pedigree
3
2000
485
0.050
Why?
Leukopenia
5
1995
28
0.050
Why?
Pyrimidines
1
2024
444
0.050
Why?
Kinins
1
2001
3
0.050
Why?
Endpoint Determination
1
2001
75
0.050
Why?
Double-Blind Method
2
2019
1860
0.050
Why?
Fluorescence
1
2001
158
0.050
Why?
HIV Infections
1
1996
2703
0.050
Why?
Receptors, Antigen, T-Cell
1
1985
701
0.050
Why?
Neoplastic Cells, Circulating
2
1984
69
0.040
Why?
Leukemia, Plasma Cell
1
1980
4
0.040
Why?
Paraproteinemias
1
1980
4
0.040
Why?
Hypergammaglobulinemia
1
1980
9
0.040
Why?
Central Nervous System
1
2023
255
0.040
Why?
Plasmacytoma
1
1980
16
0.040
Why?
Endothelium, Vascular
2
2004
871
0.040
Why?
Sensitivity and Specificity
3
2015
1820
0.040
Why?
Lymphoproliferative Disorders
3
1988
53
0.040
Why?
Cell Count
3
1996
314
0.040
Why?
Microscopy, Fluorescence
1
2002
402
0.040
Why?
Receptors, Interleukin-2
2
1995
65
0.040
Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2020
52
0.040
Why?
Microtubules
1
2003
260
0.040
Why?
Antioxidants
1
2004
543
0.040
Why?
Ploidies
4
2003
17
0.040
Why?
Telomerase
1
2002
231
0.040
Why?
Histocompatibility Antigens Class II
2
2020
359
0.040
Why?
Receptors, Virus
1
2020
83
0.040
Why?
Genes, Tumor Suppressor
1
2000
86
0.040
Why?
Lipoxygenase Inhibitors
1
1999
35
0.040
Why?
Algorithms
3
2015
1616
0.040
Why?
Observer Variation
1
2020
315
0.040
Why?
ELAV Proteins
1
1999
14
0.040
Why?
Gene Transfer Techniques
2
1998
161
0.040
Why?
Costs and Cost Analysis
1
2000
208
0.040
Why?
Carcinoembryonic Antigen
1
1979
41
0.040
Why?
Sepsis
3
1981
556
0.040
Why?
Stomach Diseases
1
1979
20
0.040
Why?
Streptomycin
8
1954
16
0.040
Why?
Feasibility Studies
2
2000
860
0.040
Why?
Electrons
4
1989
78
0.040
Why?
Light
1
2001
355
0.040
Why?
Stomach
1
1979
109
0.040
Why?
Antibodies
3
1990
391
0.040
Why?
gamma Catenin
1
2018
13
0.040
Why?
Protein Kinase C
1
2000
252
0.040
Why?
Desmoglein 3
1
2018
16
0.040
Why?
Spinal Cord Injuries
1
2002
189
0.040
Why?
Administration, Topical
2
1994
144
0.040
Why?
History, 20th Century
2
1996
291
0.040
Why?
Smokers
1
2019
137
0.040
Why?
Case-Control Studies
3
2012
3326
0.040
Why?
Teaching
1
2020
209
0.040
Why?
HIV Wasting Syndrome
1
1998
4
0.040
Why?
Bronchial Diseases
1
2018
38
0.040
Why?
Postoperative Care
1
2000
243
0.040
Why?
Tissue Distribution
5
1990
290
0.040
Why?
RNA, Small Interfering
2
2012
571
0.040
Why?
Carcinoma
4
2001
214
0.040
Why?
Hematologic Diseases
3
1995
61
0.040
Why?
Gastrin-Releasing Peptide
2
1996
7
0.040
Why?
Models, Molecular
2
2018
1481
0.040
Why?
Colorectal Neoplasms
2
2013
753
0.040
Why?
Skin Diseases
2
1979
142
0.040
Why?
Pneumonia
6
1968
599
0.040
Why?
Retinoblastoma Binding Proteins
1
2017
5
0.040
Why?
Genes, p53
1
1998
70
0.040
Why?
Organoids
1
2019
104
0.040
Why?
DNA Topoisomerases, Type I
1
2017
16
0.040
Why?
Type C Phospholipases
1
1998
72
0.040
Why?
Communicable Diseases
4
1964
143
0.040
Why?
Preoperative Care
1
2000
342
0.040
Why?
North America
1
1998
289
0.040
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1998
181
0.040
Why?
Web Browser
1
2017
12
0.030
Why?
Drug Resistance, Multiple
1
1997
21
0.030
Why?
Receptors, Notch
1
2017
80
0.030
Why?
Demecolcine
1
1976
1
0.030
Why?
Endocarditis, Subacute Bacterial
3
1964
3
0.030
Why?
Mice, SCID
1
2017
345
0.030
Why?
Risk
5
2001
852
0.030
Why?
Bronchial Neoplasms
1
1996
14
0.030
Why?
B-Lymphocytes
5
1986
820
0.030
Why?
Platinum
1
2016
44
0.030
Why?
Maximum Tolerated Dose
2
2007
193
0.030
Why?
T-Lymphocytes, Helper-Inducer
2
1996
136
0.030
Why?
Registries
1
2024
1878
0.030
Why?
Tuberculosis, Ocular
5
1954
7
0.030
Why?
Ubiquitin-Protein Ligases
1
2017
153
0.030
Why?
Antineoplastic Agents, Immunological
1
2018
173
0.030
Why?
Mitogens
4
1998
58
0.030
Why?
Endocarditis
3
1964
32
0.030
Why?
Longitudinal Studies
1
2003
2697
0.030
Why?
Carcinogenesis
1
2017
209
0.030
Why?
Receptors, Cytokine
1
1996
35
0.030
Why?
Drug Stability
1
1996
144
0.030
Why?
RNA-Binding Proteins
1
1999
379
0.030
Why?
Mice, Inbred NOD
1
2017
582
0.030
Why?
Premedication
1
1995
40
0.030
Why?
Comorbidity
2
2016
1540
0.030
Why?
Analgesics, Non-Narcotic
1
1997
122
0.030
Why?
Diet
1
2003
1200
0.030
Why?
Growth Inhibitors
2
2002
43
0.030
Why?
Colonic Neoplasms
1
2018
240
0.030
Why?
Rabbits
10
2005
761
0.030
Why?
Meningitis
4
1974
80
0.030
Why?
Hematopoiesis
1
1976
185
0.030
Why?
Cross-Linking Reagents
1
1996
205
0.030
Why?
Pathology, Molecular
1
2015
25
0.030
Why?
GTP-Binding Proteins
1
1996
155
0.030
Why?
Severity of Illness Index
1
2003
2736
0.030
Why?
Interferon-beta
1
1995
87
0.030
Why?
Drug Tolerance
1
1995
82
0.030
Why?
Military Medicine
1
1996
61
0.030
Why?
HLA-A Antigens
2
1985
53
0.030
Why?
Biological Specimen Banks
1
1996
96
0.030
Why?
Ovarian Neoplasms
1
2000
489
0.030
Why?
HLA-C Antigens
2
1985
35
0.030
Why?
Guinea Pigs
3
2005
156
0.030
Why?
Diphtheria Toxin
1
1995
61
0.030
Why?
Photopheresis
1
1994
9
0.030
Why?
HLA-B Antigens
2
1985
62
0.030
Why?
Bone Marrow Transplantation
2
1986
268
0.030
Why?
Whole-Body Irradiation
3
1991
75
0.030
Why?
Wnt Signaling Pathway
1
2016
166
0.030
Why?
Colorado
2
2014
4392
0.030
Why?
Antigens, Viral
4
1984
174
0.030
Why?
Mitomycin
2
1992
31
0.030
Why?
Glioblastoma
1
2018
320
0.030
Why?
Proteins
1
2000
936
0.030
Why?
Cholecystokinin
1
1994
14
0.030
Why?
Molecular Diagnostic Techniques
1
2015
97
0.030
Why?
Cell Cycle Proteins
1
2018
580
0.030
Why?
Methoxsalen
1
1994
4
0.030
Why?
Substance P
1
1994
43
0.030
Why?
Ultraviolet Therapy
1
1994
18
0.030
Why?
gamma-Globulins
2
1965
18
0.030
Why?
Research
2
1994
409
0.030
Why?
Histiocytoma, Benign Fibrous
1
1994
8
0.030
Why?
Contraindications
1
1994
88
0.030
Why?
Texas
1
2014
227
0.030
Why?
Glioma
1
2018
352
0.030
Why?
Pyridazines
1
2014
50
0.030
Why?
Odds Ratio
1
2016
1022
0.030
Why?
Serum Albumin
2
2013
145
0.030
Why?
Micrococcus
3
1958
4
0.030
Why?
Tumor Stem Cell Assay
3
1992
32
0.030
Why?
Fibroblasts
1
1998
939
0.030
Why?
Staphylococcus
3
1970
74
0.030
Why?
Safety
1
1995
329
0.030
Why?
DNA-Binding Proteins
1
2000
1415
0.030
Why?
Endoscopy
1
2015
267
0.030
Why?
DNA Fingerprinting
1
2013
25
0.030
Why?
Muscle Denervation
1
1973
10
0.030
Why?
Sex Hormone-Binding Globulin
1
2013
53
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2014
326
0.030
Why?
In Vitro Techniques
5
2002
1043
0.030
Why?
Ileum
2
2005
115
0.030
Why?
Consensus
1
2016
633
0.030
Why?
Maintenance Chemotherapy
1
2013
22
0.030
Why?
Urinary Tract Infections
3
1970
150
0.030
Why?
Solid Phase Microextraction
1
2012
6
0.030
Why?
Imidazoles
1
2014
228
0.030
Why?
Radiation Dosage
2
1992
152
0.030
Why?
Treatment Failure
1
1994
342
0.030
Why?
Magnetic Resonance Imaging
2
2023
3366
0.030
Why?
Auditory Perception
1
2014
111
0.030
Why?
DNA Primers
2
2009
510
0.030
Why?
NAD(P)H Dehydrogenase (Quinone)
1
1992
31
0.030
Why?
Neuromuscular Junction
1
1973
57
0.030
Why?
Chromosome Banding
4
1996
21
0.030
Why?
Luteinizing Hormone
1
2013
178
0.020
Why?
Gas Chromatography-Mass Spectrometry
1
2012
126
0.020
Why?
International Cooperation
2
2003
173
0.020
Why?
Breath Tests
1
2012
89
0.020
Why?
Hearing
1
2014
134
0.020
Why?
Mitomycins
2
1984
4
0.020
Why?
Recombinant Fusion Proteins
1
1995
632
0.020
Why?
Cooperative Behavior
1
2015
425
0.020
Why?
Pyrimidinones
1
2013
102
0.020
Why?
Adrenocorticotropic Hormone
4
1954
132
0.020
Why?
Bone Marrow Examination
1
1992
6
0.020
Why?
Ionomycin
1
1992
24
0.020
Why?
Species Specificity
2
2005
567
0.020
Why?
Ricin
1
1991
8
0.020
Why?
Probability
3
2009
308
0.020
Why?
Equipment Design
1
2014
518
0.020
Why?
Nanostructures
1
2013
99
0.020
Why?
Immunization, Passive
2
2001
85
0.020
Why?
Chromosome Deletion
2
1982
102
0.020
Why?
Properdin
2
1962
8
0.020
Why?
Benzimidazoles
1
2013
158
0.020
Why?
Radiometry
1
1992
48
0.020
Why?
Gene Frequency
1
2013
504
0.020
Why?
Follicle Stimulating Hormone
1
2013
239
0.020
Why?
Liver
5
1987
1827
0.020
Why?
Drug Hypersensitivity
2
1970
81
0.020
Why?
Ambulatory Care
1
1995
506
0.020
Why?
Fatigue
2
2005
320
0.020
Why?
Immunosorbent Techniques
1
1991
19
0.020
Why?
Logistic Models
1
2016
1975
0.020
Why?
Pyridones
1
2013
159
0.020
Why?
Tuberculosis, Pulmonary
4
1959
137
0.020
Why?
Waldenstrom Macroglobulinemia
2
1982
11
0.020
Why?
Laboratories
2
1963
108
0.020
Why?
Acquired Immunodeficiency Syndrome
2
1990
222
0.020
Why?
Lomustine
7
1986
14
0.020
Why?
Iceland
1
2011
10
0.020
Why?
Japan
2
2009
98
0.020
Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
12
0.020
Why?
Evidence-Based Medicine
1
2015
717
0.020
Why?
Vimentin
1
2011
50
0.020
Why?
Perception
1
2014
337
0.020
Why?
Spain
1
2011
36
0.020
Why?
Antibodies, Anti-Idiotypic
1
1991
57
0.020
Why?
Enzyme-Linked Immunosorbent Assay
2
2009
814
0.020
Why?
Adsorption
1
1991
138
0.020
Why?
Netherlands
1
2011
77
0.020
Why?
Mutation, Missense
1
2013
317
0.020
Why?
Zinc Finger E-box Binding Homeobox 2
1
2010
5
0.020
Why?
Residence Characteristics
1
2014
324
0.020
Why?
Cross-Sectional Studies
2
2015
5040
0.020
Why?
Motor Neurons
1
1973
237
0.020
Why?
Photochemotherapy
2
1980
32
0.020
Why?
Databases, Factual
1
1996
1268
0.020
Why?
Megakaryocytes
3
1980
31
0.020
Why?
Tissue Array Analysis
1
2010
56
0.020
Why?
Diagnosis, Differential
2
2002
1416
0.020
Why?
Sequence Homology, Nucleic Acid
1
1990
149
0.020
Why?
Serine Endopeptidases
1
2010
117
0.020
Why?
Radiotherapy, High-Energy
2
1980
13
0.020
Why?
Base Sequence
2
2009
2134
0.020
Why?
Thyroid Neoplasms
1
1994
311
0.020
Why?
Antibody-Dependent Cell Cytotoxicity
2
1988
20
0.020
Why?
Clone Cells
3
1985
254
0.020
Why?
Nervous System Diseases
3
1985
251
0.020
Why?
Carrier Proteins
1
1994
731
0.020
Why?
Nicotinic Acids
3
1954
6
0.020
Why?
Hemagglutination Tests
2
1964
7
0.020
Why?
Niacin
3
1954
19
0.020
Why?
Down-Regulation
1
1992
629
0.020
Why?
Mitosis
3
1981
178
0.020
Why?
Bacterial Infections
2
2001
227
0.020
Why?
Calcitriol
2
1986
55
0.020
Why?
Deafness
1
1970
80
0.020
Why?
Diethylstilbestrol
2
1986
9
0.020
Why?
Isoniazid
3
1954
60
0.020
Why?
Personality Inventory
1
2009
136
0.020
Why?
Infusions, Parenteral
2
1986
38
0.020
Why?
Immunoprecipitation
1
2009
157
0.020
Why?
Insulin-Like Growth Factor I
1
1991
307
0.020
Why?
Referral and Consultation
1
2014
727
0.020
Why?
Thoracic Surgery
1
2010
122
0.020
Why?
Ovary
1
1990
214
0.020
Why?
Histocytochemistry
3
1983
81
0.020
Why?
Tuberculosis, Meningeal
4
1964
6
0.020
Why?
Herpes Simplex
2
1987
93
0.020
Why?
Tomography, X-Ray Computed
3
2002
2521
0.020
Why?
Statistics, Nonparametric
1
2009
423
0.020
Why?
Fluorescent Antibody Technique
2
1987
374
0.020
Why?
Intracellular Signaling Peptides and Proteins
1
2011
425
0.020
Why?
Pulmonary Fibrosis
2
1986
374
0.020
Why?
In Situ Hybridization
1
2008
292
0.020
Why?
Tetracycline
2
1958
12
0.020
Why?
Bone Marrow Cells
3
1980
294
0.020
Why?
New South Wales
1
2007
14
0.020
Why?
Rosette Formation
2
1987
16
0.020
Why?
Queensland
1
2007
40
0.020
Why?
Ampicillin
2
1965
14
0.020
Why?
Eye
3
1954
103
0.020
Why?
Protein Synthesis Inhibitors
2
1958
41
0.020
Why?
Immunophenotyping
2
2001
312
0.020
Why?
Actuarial Analysis
1
1987
25
0.020
Why?
Body Fluids
2
1964
62
0.020
Why?
Remission, Spontaneous
4
1980
38
0.020
Why?
Fluorouracil
2
1998
197
0.020
Why?
Repressor Proteins
1
2010
400
0.020
Why?
Pneumonia, Pneumococcal
2
1960
40
0.020
Why?
Procarbazine
5
1986
8
0.020
Why?
Receptors, Progesterone
1
1989
345
0.020
Why?
Dyspnea
2
1986
234
0.020
Why?
Hydrocortisone
2
1981
301
0.020
Why?
Principal Component Analysis
1
2007
184
0.020
Why?
Genome, Human
1
2009
392
0.020
Why?
Calcitonin
1
1986
25
0.020
Why?
Nucleotidases
2
1985
7
0.020
Why?
Colony-Forming Units Assay
1
1986
90
0.020
Why?
Genome
1
2009
277
0.020
Why?
California
1
2008
400
0.020
Why?
Reference Values
1
2008
780
0.020
Why?
Bacillus
2
1957
16
0.020
Why?
Phosphates
2
1958
167
0.020
Why?
DNA Repair
1
2008
205
0.020
Why?
Sulfadiazine
1
1966
4
0.020
Why?
Nocardia Infections
1
1966
8
0.020
Why?
Gram-Positive Bacteria
2
1957
45
0.020
Why?
Antigen-Antibody Reactions
1
1966
51
0.020
Why?
Radioisotope Dilution Technique
1
1986
13
0.020
Why?
Farmer's Lung
1
1965
3
0.020
Why?
Immunoglobulin Idiotypes
1
1986
27
0.020
Why?
Insecta
2
1957
64
0.020
Why?
Dose-Response Relationship, Immunologic
1
1986
81
0.020
Why?
Vomiting
3
2001
128
0.020
Why?
Erythromycin
2
1958
22
0.020
Why?
Mice, Inbred A
1
2005
47
0.020
Why?
Child
4
2009
20721
0.020
Why?
Deoxyribonucleosides
1
1985
2
0.020
Why?
Urea
1
1966
75
0.020
Why?
Databases, Nucleic Acid
1
2005
33
0.020
Why?
Dose-Response Relationship, Radiation
1
1986
132
0.020
Why?
Indicators and Reagents
1
1986
104
0.020
Why?
Peritonitis
1
1966
79
0.020
Why?
Child, Preschool
3
2007
10373
0.020
Why?
Freezing
1
1986
86
0.020
Why?
DNA Damage
1
2008
364
0.020
Why?
Mathematics
1
1986
103
0.020
Why?
Cell Movement
2
1981
937
0.020
Why?
HLA-B35 Antigen
1
1985
3
0.020
Why?
Blood
1
1985
100
0.020
Why?
Analysis of Variance
1
2008
1271
0.020
Why?
Enzymes
1
2005
64
0.020
Why?
HLA-B8 Antigen
1
1985
14
0.020
Why?
Mycoses
1
1966
70
0.020
Why?
Bleomycin
2
1978
240
0.020
Why?
Carcinogens
1
2005
110
0.020
Why?
Phenylalanine
1
2005
65
0.020
Why?
Nucleic Acid Hybridization
1
1985
188
0.020
Why?
Lymphokines
1
1985
115
0.020
Why?
Antigens, Differentiation, T-Lymphocyte
1
1985
87
0.020
Why?
Genes, MHC Class II
1
1985
72
0.010
Why?
Myeloma Proteins
1
1984
14
0.010
Why?
Haemophilus
1
1965
6
0.010
Why?
Exanthema
1
2005
70
0.010
Why?
Melphalan
1
1984
29
0.010
Why?
Endocytosis
1
1986
161
0.010
Why?
Histocompatibility Testing
1
1985
120
0.010
Why?
Viral Proteins
3
1981
321
0.010
Why?
Carmustine
1
1984
50
0.010
Why?
Monocytes
2
1985
541
0.010
Why?
Tyrosine
1
2005
216
0.010
Why?
Syndrome
3
1984
335
0.010
Why?
Endocarditis, Bacterial
1
1965
41
0.010
Why?
Cross Reactions
1
1984
127
0.010
Why?
Psychology, Child
1
2004
36
0.010
Why?
Nausea
2
2001
108
0.010
Why?
Hemagglutination
1
1964
8
0.010
Why?
Bronchopneumonia
1
1964
6
0.010
Why?
DNA, Recombinant
1
1984
46
0.010
Why?
Acetaminophen
1
1987
249
0.010
Why?
Acute Disease
2
1984
968
0.010
Why?
Genome-Wide Association Study
1
2011
1337
0.010
Why?
Expectorants
1
1964
23
0.010
Why?
DNA Replication
1
2005
224
0.010
Why?
Nephritis, Interstitial
1
1984
13
0.010
Why?
Nephrosis, Lipoid
1
1984
10
0.010
Why?
Hypersensitivity, Delayed
1
1983
28
0.010
Why?
Gene Expression Regulation, Enzymologic
1
2005
283
0.010
Why?
Densitometry
2
1980
33
0.010
Why?
Chromosomes, Human, Pair 7
1
2003
15
0.010
Why?
Cell Transformation, Viral
2
1984
27
0.010
Why?
Prednisone
1
1984
236
0.010
Why?
Chromosomes
2
1982
101
0.010
Why?
Paraneoplastic Syndromes
1
1983
12
0.010
Why?
Muscles
3
1982
323
0.010
Why?
3',5'-Cyclic-GMP Phosphodiesterases
1
2003
17
0.010
Why?
Toxicology
1
1964
42
0.010
Why?
Virus Diseases
1
1966
204
0.010
Why?
Growth Hormone
2
1954
96
0.010
Why?
Allergy and Immunology
1
1964
43
0.010
Why?
Biopsy, Needle
2
1982
189
0.010
Why?
Cloxacillin
1
1963
1
0.010
Why?
Transfer Factor
1
1983
1
0.010
Why?
Vitamins
1
2004
172
0.010
Why?
Vital Capacity
1
2004
289
0.010
Why?
Tuberculosis, Miliary
3
1964
5
0.010
Why?
Furunculosis
1
1962
1
0.010
Why?
Sex Ratio
1
1983
14
0.010
Why?
Razoxane
1
1982
1
0.010
Why?
Receptors, Bradykinin
1
2002
4
0.010
Why?
Leukapheresis
1
1983
21
0.010
Why?
Thymosin
2
1980
5
0.010
Why?
Antilymphocyte Serum
1
1983
63
0.010
Why?
Poly(ADP-ribose) Polymerases
1
2003
87
0.010
Why?
Cell Membrane
2
2002
722
0.010
Why?
Drainage
1
1964
165
0.010
Why?
Pneumococcal Infections
2
1956
110
0.010
Why?
Mycobacterium tuberculosis
2
1957
314
0.010
Why?
T-Lymphocytes, Cytotoxic
1
1983
168
0.010
Why?
Nucleoside Deaminases
1
1982
2
0.010
Why?
Pentosyltransferases
1
1982
6
0.010
Why?
Purine-Nucleoside Phosphorylase
1
1982
5
0.010
Why?
Lymphocyte Activation
3
1983
1098
0.010
Why?
Autopsy
1
1983
92
0.010
Why?
Streptococcal Infections
1
1965
144
0.010
Why?
Cells, Cultured
7
1985
4008
0.010
Why?
Forced Expiratory Volume
1
2004
509
0.010
Why?
Adenosine Deaminase
1
1982
28
0.010
Why?
Bacteriophages
2
1961
92
0.010
Why?
Keratins
1
2003
175
0.010
Why?
Cysteine
1
1964
188
0.010
Why?
Immunity, Cellular
2
1984
267
0.010
Why?
Agglutinins
1
1962
2
0.010
Why?
Gastrointestinal Tract
1
2004
182
0.010
Why?
Umbilical Cord
1
2002
84
0.010
Why?
Clinical Enzyme Tests
1
1982
11
0.010
Why?
Aggression
1
2004
196
0.010
Why?
Phosphopyruvate Hydratase
1
1982
27
0.010
Why?
Leukemia, Erythroblastic, Acute
1
1982
7
0.010
Why?
Abdominal Neoplasms
1
1982
32
0.010
Why?
Receptors, Fc
1
1982
52
0.010
Why?
Manipulation, Spinal
1
2002
7
0.010
Why?
Caspases
1
2003
242
0.010
Why?
Rectal Diseases
1
1981
19
0.010
Why?
Complement System Proteins
2
1962
306
0.010
Why?
Bone Resorption
1
1982
81
0.010
Why?
False Positive Reactions
1
2002
113
0.010
Why?
Sulfonamides
2
1955
500
0.010
Why?
Herpesvirus 4, Human
2
1980
151
0.010
Why?
Receptors, Immunologic
1
1983
209
0.010
Why?
Immune System
1
1983
177
0.010
Why?
Oculomotor Muscles
2
1951
38
0.010
Why?
Promoter Regions, Genetic
1
2006
1199
0.010
Why?
CD52 Antigen
1
2001
4
0.010
Why?
Spinal Fractures
1
2002
81
0.010
Why?
Alemtuzumab
1
2001
15
0.010
Why?
Zymosan
1
1961
65
0.010
Why?
Carcinoma, Hepatocellular
1
1983
269
0.010
Why?
Glasgow Coma Scale
1
2002
170
0.010
Why?
Phenotype
4
1984
3050
0.010
Why?
APUD Cells
1
1980
1
0.010
Why?
Furocoumarins
1
1980
8
0.010
Why?
Single-Blind Method
1
2001
269
0.010
Why?
Neoplasms, Hormone-Dependent
1
2000
38
0.010
Why?
Polysaccharides
1
1961
81
0.010
Why?
Hypersensitivity
1
1964
249
0.010
Why?
Cell Line, Transformed
1
2000
140
0.010
Why?
Amyloidosis
1
1980
39
0.010
Why?
Hospitals, Chronic Disease
2
1958
2
0.010
Why?
Immunoglobulin Heavy Chains
1
1980
80
0.010
Why?
Intestinal Neoplasms
1
1980
28
0.010
Why?
Chromosomes, Human
1
1980
41
0.010
Why?
Biological Assay
1
2001
118
0.010
Why?
Piperazines
1
1982
334
0.010
Why?
Leukocytes
2
1984
303
0.010
Why?
Cytological Techniques
1
1980
26
0.010
Why?
Neoplasm, Residual
1
2001
118
0.010
Why?
Quality Assurance, Health Care
1
2002
316
0.010
Why?
Health Resources
1
2001
120
0.010
Why?
Anemia
1
2001
156
0.010
Why?
Antiviral Agents
1
1966
704
0.010
Why?
Soft Tissue Neoplasms
1
1981
112
0.010
Why?
Bacteremia
1
1962
188
0.010
Why?
Disease Management
1
1964
588
0.010
Why?
Influenza, Human
1
1985
596
0.010
Why?
Thymus Hormones
1
1979
1
0.010
Why?
Brain
3
1985
2618
0.010
Why?
Carcinogens, Environmental
1
1979
7
0.010
Why?
Range of Motion, Articular
1
2002
387
0.010
Why?
Stomach Ulcer
1
1979
11
0.010
Why?
Joint Instability
1
2002
181
0.010
Why?
Gastroscopy
1
1979
18
0.010
Why?
Spinal Cord
1
1982
354
0.010
Why?
Duodenal Ulcer
1
1979
11
0.010
Why?
Osteoporosis
1
1982
233
0.010
Why?
History, 19th Century
1
1979
57
0.010
Why?
Glycoproteins
1
2001
337
0.010
Why?
Semustine
1
1978
1
0.010
Why?
Cost-Benefit Analysis
1
2002
581
0.010
Why?
Hybridomas
2
1994
234
0.010
Why?
Neuroblastoma
1
1980
154
0.010
Why?
Demeclocycline
1
1978
3
0.010
Why?
Spinal Cord Compression
1
1978
19
0.010
Why?
Blood Platelets
2
1984
369
0.010
Why?
Protein Biosynthesis
1
2000
397
0.010
Why?
Antigens, CD
1
2001
479
0.010
Why?
Polymorphism, Single-Stranded Conformational
1
1998
28
0.010
Why?
Phospholipase C beta
1
1998
28
0.010
Why?
Chloramphenicol
1
1958
9
0.010
Why?
Levamisole
1
1998
21
0.010
Why?
Vasopressins
1
1978
62
0.010
Why?
Gastritis
1
1979
97
0.010
Why?
Radiation Injuries
1
1979
137
0.010
Why?
Antibody Specificity
3
1983
182
0.010
Why?
Practice Patterns, Physicians'
1
2006
1266
0.010
Why?
Estradiol
1
1981
497
0.010
Why?
Cell Separation
3
1986
313
0.010
Why?
Hormones, Ectopic
1
1977
2
0.010
Why?
T-Lymphocytes, Regulatory
1
1980
374
0.010
Why?
Occupational Diseases
1
1979
141
0.010
Why?
Amantadine
2
1968
6
0.010
Why?
Thoracotomy
1
1997
74
0.010
Why?
GPI-Linked Proteins
1
1997
67
0.010
Why?
Vinca Alkaloids
1
1976
4
0.010
Why?
Genetic Markers
1
1998
339
0.010
Why?
Capsules
1
1957
37
0.010
Why?
Staining and Labeling
1
1977
139
0.010
Why?
Penicillin V
1
1956
3
0.010
Why?
Cephalosporins
2
1968
35
0.010
Why?
Immunoglobulin G
2
1994
837
0.010
Why?
Cycloserine
1
1956
4
0.010
Why?
Gentamicins
2
1968
52
0.010
Why?
Colchicine
1
1976
25
0.010
Why?
Pregnancy
1
1989
6297
0.010
Why?
Novobiocin
1
1956
5
0.010
Why?
Gallium Radioisotopes
1
1975
14
0.010
Why?
Maryland
1
1996
42
0.010
Why?
Herpes Zoster
1
1980
317
0.010
Why?
Computer Communication Networks
1
1996
32
0.010
Why?
Sulfisoxazole
1
1955
1
0.010
Why?
Arthritis
1
1957
114
0.010
Why?
Glycopeptides
1
1996
44
0.010
Why?
Laparoscopy
1
1980
454
0.010
Why?
Cerebrospinal Fluid
1
1976
89
0.010
Why?
Cyclic AMP
1
1996
230
0.010
Why?
Bronchoalveolar Lavage Fluid
1
1997
626
0.010
Why?
Folate Receptors, GPI-Anchored
1
1994
5
0.010
Why?
Streptococcus pneumoniae
1
1956
159
0.010
Why?
Portal System
1
1953
12
0.010
Why?
Phlebitis
1
1953
11
0.010
Why?
Leucomycins
1
1953
1
0.010
Why?
Dogs
2
1987
366
0.010
Why?
Respiratory Function Tests
2
1986
582
0.010
Why?
Veins
1
1953
59
0.010
Why?
Heart Neoplasms
1
1994
49
0.010
Why?
Isomerism
1
1953
48
0.010
Why?
Thyroid Gland
1
1994
94
0.010
Why?
Gallamine Triethiodide
1
1973
1
0.010
Why?
Edrophonium
1
1973
2
0.010
Why?
Pulmonary Alveoli
1
1996
366
0.010
Why?
Organ Specificity
1
1994
291
0.010
Why?
Disease
1
1953
94
0.010
Why?
Sciatic Nerve
1
1973
60
0.010
Why?
Human Growth Hormone
1
1953
44
0.010
Why?
Cats
1
1973
210
0.010
Why?
Chromosomes, Human, 1-3
2
1982
2
0.010
Why?
RNA, Neoplasm
1
1992
87
0.010
Why?
Meningitis, Pneumococcal
1
1952
7
0.010
Why?
Killer Cells, Lymphokine-Activated
1
1992
12
0.010
Why?
Cytotoxicity, Immunologic
2
1983
218
0.010
Why?
Appendicitis
1
1953
132
0.010
Why?
Electric Stimulation
1
1973
269
0.010
Why?
Recurrence
3
1980
1001
0.010
Why?
Models, Biological
1
1979
1693
0.010
Why?
Hormones
1
1952
140
0.010
Why?
Evaluation Studies as Topic
2
1982
172
0.010
Why?
Erythrocytes
1
1976
670
0.010
Why?
Perfusion
1
1992
188
0.010
Why?
Vestibulocochlear Nerve
1
1970
7
0.010
Why?
Klebsiella
1
1970
4
0.010
Why?
Blood Cell Count
2
1981
54
0.010
Why?
Organ of Corti
1
1970
14
0.010
Why?
Synaptic Transmission
1
1973
260
0.010
Why?
Chlortetracycline
1
1950
4
0.010
Why?
Insulin
1
1981
2318
0.010
Why?
Drug Resistance, Microbial
1
1970
63
0.010
Why?
Injections
1
1991
170
0.010
Why?
Enterobacteriaceae Infections
1
1970
36
0.010
Why?
Culture Media
2
1981
167
0.010
Why?
Kidney
2
1984
1305
0.010
Why?
Microscopy, Electron
2
1982
417
0.010
Why?
Paralysis
1
1970
72
0.010
Why?
Muscle Contraction
1
1973
421
0.010
Why?
Promegestone
1
1989
33
0.010
Why?
Action Potentials
1
1973
469
0.010
Why?
Chickenpox
1
1950
78
0.010
Why?
Formaldehyde
1
1989
57
0.000
Why?
Neuromuscular Diseases
1
1970
106
0.000
Why?
DNA Nucleotidyltransferases
1
1968
11
0.000
Why?
Thrombocythemia, Essential
1
1988
7
0.000
Why?
Polymyxins
1
1968
9
0.000
Why?
Immunoglobulin Isotypes
1
1987
34
0.000
Why?
Hepatic Insufficiency
1
1947
4
0.000
Why?
Whole-Body Counting
1
1987
6
0.000
Why?
Lysosomes
1
1968
136
0.000
Why?
Propidium
1
1986
8
0.000
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
1988
111
0.000
Why?
Medroxyprogesterone
1
1986
10
0.000
Why?
Infant
1
1980
8913
0.000
Why?
Kidney Diseases
1
1970
368
0.000
Why?
Medroxyprogesterone Acetate
1
1986
35
0.000
Why?
Coloring Agents
1
1986
76
0.000
Why?
Orchiectomy
1
1986
65
0.000
Why?
Cephaloridine
1
1966
1
0.000
Why?
Immunoglobulin M
1
1987
268
0.000
Why?
Immunodiffusion
1
1965
15
0.000
Why?
Sulfanilamides
2
1955
2
0.000
Why?
Polymers
1
1989
471
0.000
Why?
Spleen
1
1987
513
0.000
Why?
Immunization
1
1987
411
0.000
Why?
Tuberculosis, Renal
1
1964
1
0.000
Why?
Canada
1
1965
345
0.000
Why?
Death, Sudden
1
1964
24
0.000
Why?
Memory Disorders
1
1985
158
0.000
Why?
Purines
1
1985
169
0.000
Why?
Pathology
1
1964
22
0.000
Why?
Molecular Weight
1
1984
331
0.000
Why?
Polyethylene Glycols
1
1989
597
0.000
Why?
Blood Cells
1
1984
38
0.000
Why?
Urticaria
1
1984
37
0.000
Why?
West Indies
1
1983
4
0.000
Why?
Cell Differentiation
2
1985
1883
0.000
Why?
Leucovorin
1
1983
68
0.000
Why?
Alabama
1
1983
31
0.000
Why?
Leukemia, Hairy Cell
1
1983
6
0.000
Why?
Aspartate Aminotransferases
1
1983
85
0.000
Why?
Georgia
1
1983
79
0.000
Why?
Florida
1
1983
92
0.000
Why?
Skin Tests
1
1983
100
0.000
Why?
Respiratory Tract Infections
1
1968
370
0.000
Why?
Warfarin
1
1984
147
0.000
Why?
Osteosclerosis
1
1982
2
0.000
Why?
Anemia, Sideroblastic
1
1982
3
0.000
Why?
Pulmonary Embolism
1
1964
208
0.000
Why?
Adrenal Glands
1
1982
71
0.000
Why?
Agranulocytosis
1
1981
32
0.000
Why?
Leukocyte Count
1
1982
327
0.000
Why?
Technetium Tc 99m Pyrophosphate
1
1981
1
0.000
Why?
Technetium
1
1981
11
0.000
Why?
Creatinine
1
1983
475
0.000
Why?
Viral Core Proteins
1
1981
21
0.000
Why?
Electrophysiology
1
1982
205
0.000
Why?
Peripheral Nerves
1
1982
66
0.000
Why?
Diphosphates
1
1981
17
0.000
Why?
Transferrin
1
1981
42
0.000
Why?
Abscess
1
1981
73
0.000
Why?
Immune Sera
1
1981
86
0.000
Why?
Fluorometry
1
1980
17
0.000
Why?
Mental Disorders
1
1949
1007
0.000
Why?
Photomicrography
1
1980
7
0.000
Why?
Microscopy, Phase-Contrast
1
1980
15
0.000
Why?
Substance-Related Disorders
1
1949
1011
0.000
Why?
DNA-Directed DNA Polymerase
1
1980
43
0.000
Why?
Haplorhini
1
1980
50
0.000
Why?
Dermatitis, Exfoliative
1
1980
4
0.000
Why?
Purpura
1
1980
12
0.000
Why?
Castration
1
1980
14
0.000
Why?
Macrophage Migration-Inhibitory Factors
1
1980
9
0.000
Why?
Alopecia
1
1979
28
0.000
Why?
Receptors, Complement
1
1980
120
0.000
Why?
Cocarcinogenesis
1
1979
14
0.000
Why?
Chemical Industry
1
1979
11
0.000
Why?
Receptors, Antigen, B-Cell
1
1980
126
0.000
Why?
Methods
1
1978
65
0.000
Why?
Fiber Optic Technology
1
1978
17
0.000
Why?
Hemoglobins
1
1981
336
0.000
Why?
Solvents
1
1979
107
0.000
Why?
Pesticides
1
1979
58
0.000
Why?
Mucous Membrane
1
1978
120
0.000
Why?
Granulocytes
1
1976
79
0.000
Why?
Herpesvirus 3, Human
1
1980
330
0.000
Why?
Air Pollutants
1
1979
311
0.000
Why?
Postoperative Complications
1
1983
2479
0.000
Why?
Hospitals, University
1
1946
175
0.000
Why?
Biological Transport
1
1946
394
0.000
Why?
Minnesota
1
1964
146
0.000
Why?
Students
1
1946
573
0.000
Why?
Bunn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)